165 related articles for article (PubMed ID: 7929532)
1. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.
Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L
J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines.
Sica G; Iacopino F; Marini L; Robustelli della Cuna G
Clin Ther; 1992; 14 Suppl A():87-96. PubMed ID: 1535023
[TBL] [Abstract][Full Text] [Related]
3. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
4. Direct antiproliferative effect of triptorelin on human breast cancer cells.
Marini L; Iacopino F; Schinzari G; Robustelli della Cuna FS; Mantovani G; Sica G
Anticancer Res; 1994; 14(5A):1881-5. PubMed ID: 7847821
[TBL] [Abstract][Full Text] [Related]
5. Direct effects of GnRH agonists in human hormone-sensitive endometrial cells.
Sica G; Schinzari G; Angelucci C; Lama G; Iacopino F
Mol Cell Endocrinol; 2001 May; 176(1-2):121-8. PubMed ID: 11369451
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
[TBL] [Abstract][Full Text] [Related]
7. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
[TBL] [Abstract][Full Text] [Related]
8. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
9. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
10. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma.
Lamb CA; Helguero LA; Fabris V; Lucas C; Molinolo AA; Lanari C
Breast Cancer Res Treat; 2003 May; 79(1):25-35. PubMed ID: 12779079
[TBL] [Abstract][Full Text] [Related]
12. The regulation of progesterone receptor by 17 beta estradiol and tamoxifen in the Zr-75-1 human breast cancer cell line in defined medium.
Allegra JC; Korat O; Do HM; Lippman M
J Recept Res; 1981; 2(1):17-27. PubMed ID: 6270327
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
Murphy CS; Pink JJ; Jordan VC
Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of buserelin, estradiol and tamoxifen on the growth of MCF-7 human breast cancer cells in vitro.
Foekens JA; Henkelman MS; Fukkink JF; Blankenstein MA; Klijn JG
Biochem Biophys Res Commun; 1986 Oct; 140(2):550-6. PubMed ID: 3096324
[TBL] [Abstract][Full Text] [Related]
16. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
Neubauer H; Yang Y; Seeger H; Fehm T; Cahill MA; Tong X; Ruan X; Mueck AO
Menopause; 2011 Aug; 18(8):845-50. PubMed ID: 21532513
[TBL] [Abstract][Full Text] [Related]
17. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
Journe F; Chaboteaux C; Dumon JC; Leclercq G; Laurent G; Body JJ
Br J Cancer; 2004 Nov; 91(9):1703-10. PubMed ID: 15477866
[TBL] [Abstract][Full Text] [Related]
18. Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line.
Devleeschouwer N; Body JJ; Legros N; Muquardt C; Donnay I; Wouters P; Leclercq G
Anticancer Res; 1992; 12(3):789-94. PubMed ID: 1622138
[TBL] [Abstract][Full Text] [Related]
19. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture.
Niwa T; Bradlow HL; Fishman J; Swaneck GE
Steroids; 1990 Jul; 55(7):297-302. PubMed ID: 2219196
[TBL] [Abstract][Full Text] [Related]
20. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
